Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data (original) (raw)

Maintenance antipsychotic medication patterns in outpatient schizophrenia patients: a naturalistic cohort study

Richard Laugharne

Acta Psychiatrica Scandinavica, 2006

View PDFchevron_right

Long-Acting Risperidone and Oral Antipsychotics in Schizophrenia

Robert Rosenheck

New England Journal of Medicine, 2011

View PDFchevron_right

Efficacy and safety of clozapine combination with different antipsychotics in schizophrenia: a systematic review

Zullies Ikawati

Indonesian Journal of Pharmacology and Therapy, 2024

View PDFchevron_right

Comparing Antipsychotic Treatments for Schizophrenia: A Health State Approach

Robert Rosenheck

Psychiatric Quarterly, 2014

View PDFchevron_right

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East

Nasser Al Zain

Neuropsychiatric Disease and Treatment, 2015

View PDFchevron_right

Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders

Noosha Niv

CNS Drugs, 2008

View PDFchevron_right

The cutlass study: A pragmatic, multicentre trial of the effectiveness and costs of atypical antipsychotic drugs in schizophrenia

Alison Markwick

Schizophrenia Research, 2000

View PDFchevron_right

Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics

Takefumi Suzuki

Journal of Clinical Psychopharmacology, 2018

View PDFchevron_right

Effectiveness of clozapine in treatment-resistant schizophrenia

Raguraman Janakiraman

Indian Journal of Psychiatry, 2005

View PDFchevron_right

Predictors of antipsychotic dose changes in the CATIE schizophrenia trial

Robert Rosenheck

Psychiatry Research, 2012

View PDFchevron_right

Antipsychotic Polypharmacy in the Treatment of Patientswith Resistant Schizophrenia: A Descriptive Study

Lama Faddoul

2017

View PDFchevron_right

The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review

Fabian Lungu

Brain sciences, 2024

View PDFchevron_right

A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia

mohammad reza khodaie

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2008

View PDFchevron_right

Effectiveness of Switching From Antipsychotic Polypharmacy to Monotherapy

Stephen Olson

American Journal of Psychiatry, 2011

View PDFchevron_right

Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness

Gretchen Haas

Journal of Psychiatric Research, 1998

View PDFchevron_right

The "Seroquel" Outcomes Study (SOS): Efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia

José Giner

International Journal of Psychiatry in Clinical Practice, 2007

View PDFchevron_right

Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends

Jonathan Favre

Current Pharmaceutical Design, 2015

View PDFchevron_right

More than Half of Patients with Schizophrenia Are Receiving Polypharmacy and Co-Prescription of Anxiolytics in Pakistan —Findings from Research on Asian Prescription Pattern in 2016

Munir Hamirani

Open Journal of Psychiatry

View PDFchevron_right

Antipsychotic management in primary care: a longitudinal population-based study

Sally Sheard

medRxiv (Cold Spring Harbor Laboratory), 2024

View PDFchevron_right

Antipsychotic Drug Utilization and Adverse Drug Reaction Profiling in Patients With Schizophrenia at a Tertiary Care Hospital in Western India

Raakhi Tripathi

Cureus

View PDFchevron_right

Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia

Glenn Phillips

Psychiatry Research, 2012

View PDFchevron_right

Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)

Michael Davidson

American Journal of Psychiatry, 2009

View PDFchevron_right

Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults

Lissette Saavedra

2012

View PDFchevron_right

Retrospective database analysis on the effectiveness of typical and atypical antipsychotic drugs in an outpatient clinic setting

SELÇUK KIRLI

Human Psychopharmacology: Clinical and Experimental, 2007

View PDFchevron_right

Clozapine versus other atypical antipsychotics for schizophrenia

Claudia Asenjo-Lobos

Cochrane Database of Systematic Reviews, 2010

View PDFchevron_right